Seeringer A - Search Results

1

Pharmacogenetics-guided dose modifications of antidepressants.

Seeringer A, Kirchheiner J. Seeringer A, et al. Clin Lab Med. 2008 Dec;28(4):619-26. doi: 10.1016/j.cll.2008.05.006. Clin Lab Med. 2008. PMID: 19059066 Review.

2

Clinical implications of pharmacogenetics of cytochrome P450 drug metabolizing enzymes.

Kirchheiner J, Seeringer A. Kirchheiner J, et al. Among authors: seeringer a. Biochim Biophys Acta. 2007 Mar;1770(3):489-94. doi: 10.1016/j.bbagen.2006.09.019. Epub 2006 Oct 4. Biochim Biophys Acta. 2007. PMID: 17113714 Review.

3

Genetic variants in FKBP5 affecting response to antidepressant drug treatment.

Kirchheiner J, Lorch R, Lebedeva E, Seeringer A, Roots I, Sasse J, Brockmöller J. Kirchheiner J, et al. Among authors: seeringer a. Pharmacogenomics. 2008 Jul;9(7):841-6. doi: 10.2217/14622416.9.7.841. Pharmacogenomics. 2008. PMID: 18597649

4

Sex-specific differences in side effects of psychotropic drugs: genes or gender?

Haack S, Seeringer A, Thürmann PA, Becker T, Kirchheiner J. Haack S, et al. Among authors: seeringer a. Pharmacogenomics. 2009 Sep;10(9):1511-26. doi: 10.2217/pgs.09.102. Pharmacogenomics. 2009. PMID: 19761372 Review.

5

Pharmacogenetics in psychiatry--a useful clinical tool or wishful thinking for the future?

Kirchheiner J, Seeringer A, Viviani R. Kirchheiner J, et al. Among authors: seeringer a. Curr Pharm Des. 2010;16(2):136-44. doi: 10.2174/138161210790112728. Curr Pharm Des. 2010. PMID: 20205659 Review.

6

[CYP2D6-, CYP2C9- and CYP2C19-based dose adjustments: when do they make sense?].

Seeringer A, Kirchheiner J. Seeringer A, et al. Internist (Berl). 2008 Jul;49(7):877-83. doi: 10.1007/s00108-008-2125-9. Internist (Berl). 2008. PMID: 18551264 Review. German.

7

Enantiospecific pharmacokinetics of metoprolol in CYP2D6 ultra-rapid metabolizers and correlation with exercise-induced heart rate.

Seeringer A, Brockmöller J, Bauer S, Kirchheiner J. Seeringer A, et al. Eur J Clin Pharmacol. 2008 Sep;64(9):883-8. doi: 10.1007/s00228-008-0504-8. Epub 2008 Jun 11. Eur J Clin Pharmacol. 2008. PMID: 18545991

8

[State of the art of pharmacogenetic diagnostics in drug therapy].

Kirchheiner J, Seeringer A, Brockmöller J. Kirchheiner J, et al. Among authors: seeringer a. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006 Oct;49(10):995-1003. doi: 10.1007/s00103-006-0045-1. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2006. PMID: 17013776 Review. German.

9

CYP2D6 in the brain: genotype effects on resting brain perfusion.

Kirchheiner J, Seeringer A, Godoy AL, Ohmle B, Maier C, Beschoner P, Sim EJ, Viviani R. Kirchheiner J, et al. Among authors: seeringer a. Mol Psychiatry. 2011 Mar;16(3):237, 333-41. doi: 10.1038/mp.2010.42. Epub 2010 Apr 6. Mol Psychiatry. 2011. PMID: 20368706

10

Genetic variants of the insulin receptor substrate-1 are influencing the therapeutic efficacy of oral antidiabetics.

Seeringer A, Parmar S, Fischer A, Altissimo B, Zondler L, Lebedeva E, Pitterle K, Roots I, Kirchheiner J. Seeringer A, et al. Diabetes Obes Metab. 2010 Dec;12(12):1106-12. doi: 10.1111/j.1463-1326.2010.01301.x. Diabetes Obes Metab. 2010. PMID: 20977583

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters